FDA’s commissioner vouchers prompt questions about award process
Despite the FDA’s CNPV scheme generating high interest, the process around how voucher awards are prioritised remains unclear.
Regulation
Medical bodies sound alarm over US hepatitis B vaccine vote
FDA appoints Tracy Beth Høeg as fifth CDER head this year
FDA inspection reveals critical supply chain vulnerabilities
EuropaBio calls for “bold approach to investment” amid EU Biotech Act
FDA’s revolving door reveals Pazdur as new CDER head
Japan’s MHLW grants orphan status to Kyowa and Orchard’s MLD therapy
FDA ‘green list’ flagging illegal GLP-1RA compounders is long overdue
